MedTrace Logo

Infrared Photomodulation Therapy for Seasonal Affective Disorder

NCT04251000 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2021-02-11

No results posted yet for this study

Summary

During winter months in northern latitudes use of Joovv device on self-reported non-clinical mental health (aka mood), sleep and energy levels. Participants will also submit Withings and Oura activity and sleep data.

Conditions

  • Seasonal Affective Disorder

Interventions

DEVICE

Joovv Mini

the smallest photomodulation device in the Joovv infrared light product line.

Sponsors & Collaborators

  • Joovv

    collaborator UNKNOWN

  • ProofPilot

    lead INDUSTRY

Study Design

Allocation
NA
Purpose
PREVENTION
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
100 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2020-02-27
Primary Completion
2020-05-31
Completion
2020-07-01
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04251000 on ClinicalTrials.gov